CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
Conditions:   Melanoma;   Melanoma Stage III
Interventions:   Diagnostic Test: PET Scan;   Drug: Nivolumab;   Drug: Ipilimumab;   Procedure: Surgical Resection of Melanoma
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 22, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments